Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Tae Sung | - |
dc.contributor.author | Choi, Jun Young | - |
dc.contributor.author | Park, Sun Ah | - |
dc.contributor.author | Youn, Young Chul | - |
dc.contributor.author | Lee, Hyun Young | - |
dc.contributor.author | Kim, Byung Gon | - |
dc.contributor.author | Joo, In Soo | - |
dc.contributor.author | Huh, Kyoon | - |
dc.contributor.author | Moon, So Young | - |
dc.date.available | 2019-03-08T21:59:51Z | - |
dc.date.issued | 2014-04 | - |
dc.identifier.issn | 1471-2377 | - |
dc.identifier.issn | 1471-2377 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/12325 | - |
dc.description.abstract | Background: We investigated levels of the beta-amyloid 1-42 (A beta 42), total tau protein (T-tau) and tau phosphorylated at position threonine 181 (P-tau) in cerebrospinal fluid (CSF) of idiopathic normal pressure hydrocephalus (iNPH) patients and tried to find their clinical implications in the evaluation and treatment of iNPH. Method: Twenty-five possible iNPH patients were prospectively enrolled and their CSF was collected to analyze levels of A beta 42, T-tau and P-tau using ELISA method. Gait disturbance, urinary incontinence, and cognitive impairment were semi-quantified and detailed neuropsychological (NP) test was performed. Result: Eight iNPH patients were classified into the lower CSF A beta 42 group and 17 patients were classified into the higher CSF A beta 42 group. There was no difference in the iNPH grading score and its improvement after LP between the two groups. The lower CSF A beta 42 group showed more deficits in attention, visuospatial function and verbal memory in the baseline NP test and less improvement in phonemic categorical naming and frontal inhibitory function after LP. Conclusions: Our study suggested that concomitant AD in iNPH patients might contribute to lumbar puncture or shunt unresponsiveness, especially in the field of cognitive dysfunction. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | BIOMED CENTRAL LTD | - |
dc.title | Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers | - |
dc.type | Article | - |
dc.identifier.doi | 10.1186/1471-2377-14-66 | - |
dc.identifier.bibliographicCitation | BMC NEUROLOGY, v.14, no.1 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000334612800001 | - |
dc.identifier.scopusid | 2-s2.0-84897527470 | - |
dc.citation.number | 1 | - |
dc.citation.title | BMC NEUROLOGY | - |
dc.citation.volume | 14 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Normal pressure hydrocephalus | - |
dc.subject.keywordAuthor | Alzheimer's disease | - |
dc.subject.keywordAuthor | Cerebrospinal fluid | - |
dc.subject.keywordAuthor | Lumbar puncture | - |
dc.subject.keywordAuthor | Neuropsychological tests | - |
dc.subject.keywordPlus | MILD COGNITIVE IMPAIRMENT | - |
dc.subject.keywordPlus | HUMAN CEREBROSPINAL-FLUID | - |
dc.subject.keywordPlus | CORTICAL BRAIN BIOPSY | - |
dc.subject.keywordPlus | TAU-PROTEIN | - |
dc.subject.keywordPlus | DIAGNOSTIC-VALUE | - |
dc.subject.keywordPlus | SHUNT RESPONSE | - |
dc.subject.keywordPlus | COMORBIDITY | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | PATHOLOGY | - |
dc.subject.keywordPlus | DEMENTIA | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.